KC

Kushala Chinmayi Krishnappakemparaju

Active Director Director DIN 10648845
DIN 10648845 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kushala Chinmayi Krishnappakemparaju

Data last updated:

Kushala Chinmayi Krishnappakemparaju is a Director at Tridala Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10648845
Primary Designation Director
Industry Pharma
First Appointment 30 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20242024Active

Board colleagues of Kushala Chinmayi Krishnappakemparaju

Directorship timeline

Open interactive timeline →
Tridala Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kushala Chinmayi Krishnappakemparaju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kushala Chinmayi Krishnappakemparaju

Kushala Chinmayi Krishnappakemparaju currently holds 1 directorship: Tridala Pharmaceuticals Private Limited (Director, since 30 May 2024).

Kushala Chinmayi Krishnappakemparaju was first appointed on 30 May 2024 as Director at Tridala Pharmaceuticals Private Limited.

The current boards of Kushala Chinmayi Krishnappakemparaju's companies include Monika Chinmayee Kadusonnappa Kemparaju (Tridala Pharmaceuticals Private Limited), Nidaghatta Puttappa Usha (Tridala Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available